ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533…
Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533…
Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET SAN JOSE,…
Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET SAN JOSE,…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Announced SC291 IND clearance with goal to report initial clinical data this year Expect to…
Company to host conference call March 16, 2023, at 4:30 PM EDT SEATTLE, Wash. and…
Company to host conference call March 16, 2023, at 4:30 PM EDT SEATTLE, Wash. and…
The Newly Issued Patent is Expected to Provide Protection into 2040 Pipeline Focus on Pan-Caspase…
The Newly Issued Patent is Expected to Provide Protection into 2040 Pipeline Focus on Pan-Caspase…
Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., March 16, 2023 (GLOBE…
Conference call and webcast today at 4:30 p.m. ET NEWARK, Calif., March 16, 2023 (GLOBE…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
The Company’s patent application describes how it plans to leverage cutting-edge CRISPR and mRNA technologies…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full…
Q4 2022 revenue of $8.5 million Q4 Product sales and royalty revenue up 220% from…
Q4 2022 revenue of $8.5 million Q4 Product sales and royalty revenue up 220% from…
Broadband service provider offers affordable, reliable, high-speed internet Fastwyre Broadband Launches High-Speed Fiber-Optic Network in…
Broadband service provider offers affordable, reliable, high-speed internet Fastwyre Broadband Launches High-Speed Fiber-Optic Network in…
Whether more buyers return to the market depends largely on how the Fed reacts to…